First Trust Capital Management’s Amedisys AMED Stock Holding History

First Trust Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22,753	Closed	-$2.24M	–	122
2025 Q2	$2.24M	Sell	22,753 -495	-2%	-$46.8K	0.15%	90
2025 Q1	$2.15M	Buy	23,248 +2,970	+15%	+$274K	0.16%	74
2024 Q4	$1.84M	Sell	20,278 -991	-5%	-$91K	0.14%	70
2024 Q3	$2.05M	Sell	21,269 -2,476	-10%	-$242K	0.14%	83
2024 Q2	$2.18M	Sell	23,745 -5,416	-19%	-$503K	0.2%	82
2024 Q1	$2.69M	Sell	29,161 -4,835	-14%	-$453K	0.23%	84
2023 Q4	$3.23M	Sell	33,996 -6,018	-15%	-$562K	0.25%	91
2023 Q3	$3.74M	Buy	+40,014	New	+$3.7M	0.21%	87

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Trust Capital Management's AMED Position: Q3 2025 in Review

First Trust Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 22,753 shares — an estimated $2.24M sold.

First Trust Capital Management first reported a position in AMED in Q3 2023 and held it in 8 quarters. The position peaked at $3.74M in Q3 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

First Trust Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
First Trust Capital Management sold 22,753 Amedisys shares in Q3 2025, an estimated $2.24M.
First Trust Capital Management first reported a position in Amedisys in Q3 2023 and held it in 8 quarters.
First Trust Capital Management's Amedisys position peaked at $3.74M in Q3 2023.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on First Trust Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.